vimarsana.com

Page 351 - Advanced Cellular Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Eying Its Next Blockbuster, Astellas Lines Up $5 9B Iveric Bio Acquisition

Astellas Pharma is acquiring Iveric Bio in a deal that brings a vision loss-disorder drug on track for an FDA decision this summer. Iveric’s pipeline also includes genetic medicines that fit Astellas’s gene therapy strategy.

Medicare, VHA Made $128M in Duplicate Payments, OIG Report Shows

Medicare could have saved $128 million if the Centers for Medicare and Medicaid Services had the correct controls in place to avoid duplicate payments with the Veterans Health Administration, an audit by the Office of Inspector General found.

ChatGPT Outperforms Doctors In Answering Patient Messages, Study Shows

A new study found that ChatGPT might actually be quite successful in providing high-quality answers to patient questions during an era in which doctors and nurses are too busy to do so. The research evaluated two sets of answers to patient inquiries one written by physicians, the other by ChatGPT. A panel of healthcare professionals determined that ChatGPT's answers were significantly more detailed and empathetic.

In Rare Move, CMS Fines 2 Hospitals for Price Transparency Violations

CMS recently fined two hospitals for alleged violations of its price transparency rule. These fines are only the third and fourth penalties issued by the agency since the rule took effect on January 1, 2021. These fines may become more common CMS also announced that it is updating its enforcement process for the rule.

MedCity INVEST Ask the Investor Spotlight: Jane Rho of DaVita Venture Group

Ask the Investor sessions at MedCity INVEST at the Ritz Carlton in Chicago May 22-24 offer opportunities for startups to talk with investors in intimate settings. Spots are limited so register today!

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.